Anti-mTOR monoclonal antibody

Pre-made anti-mTOR monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to mTOR/MTOR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T75243-Ab-1/ GM-Tg-hg-T75243-Ab-2Anti-Human mTOR/MTOR monoclonal antibodyHuman
GM-Tg-rg-T75243-Ab-1/ GM-Tg-rg-T75243-Ab-2Anti-Rat mTOR/MTOR monoclonal antibodyRat
GM-Tg-mg-T75243-Ab-1/ GM-Tg-mg-T75243-Ab-2Anti-Mouse mTOR/MTOR monoclonal antibodyMouse
GM-Tg-cynog-T75243-Ab-1/ GM-Tg-cynog-T75243-Ab-2Anti-Cynomolgus/ Rhesus macaque mTOR/MTOR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T75243-Ab-1/ GM-Tg-felg-T75243-Ab-2Anti-Feline mTOR/MTOR monoclonal antibodyFeline
GM-Tg-cang-T75243-Ab-1/ GM-Tg-cang-T75243-Ab-2Anti-Canine mTOR/MTOR monoclonal antibodyCanine
GM-Tg-bovg-T75243-Ab-1/ GM-Tg-bovg-T75243-Ab-2Anti-Bovine mTOR/MTOR monoclonal antibodyBovine
GM-Tg-equg-T75243-Ab-1/ GM-Tg-equg-T75243-Ab-2Anti-Equine mTOR/MTOR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T75243-Ab-1/ GM-Tg-hg-T75243-Ab-2; GM-Tg-rg-T75243-Ab-1/ GM-Tg-rg-T75243-Ab-2;
GM-Tg-mg-T75243-Ab-1/ GM-Tg-mg-T75243-Ab-2; GM-Tg-cynog-T75243-Ab-1/ GM-Tg-cynog-T75243-Ab-2;
GM-Tg-felg-T75243-Ab-1/ GM-Tg-felg-T75243-Ab-2; GM-Tg-cang-T75243-Ab-1/ GM-Tg-cang-T75243-Ab-2;
GM-Tg-bovg-T75243-Ab-1/ GM-Tg-bovg-T75243-Ab-2; GM-Tg-equg-T75243-Ab-1/ GM-Tg-equg-T75243-Ab-2
Products NameAnti-mTOR/MTOR monoclonal antibody
Formatmab
Target NamemTOR
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-mTOR monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T75243-Ag-1Recombinant multi-species MTOR/ mTOR/ FRAP protein


    Target information

    Target IDGM-T75243
    Target NamemTOR
    Gene ID2475,56717,56718,106992736,101098152,100139219,100051341
    Gene Symbol and Synonyms2610315D21Rik,flat,FRAP,FRAP1,FRAP2,MTOR,RAFT1,RAPT1,SKS
    Uniprot AccessionP42345,P42346
    Uniprot Entry NameMTOR_HUMAN,MTOR_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseNon-Small Cell Lung Cancer
    Gene EnsemblENSG00000198793
    Target ClassificationKinase

    The target: mTOR, gene name: MTOR, also named as FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS. The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This kinase is a component of two distinct complexes, mTORC1, which controls protein synthesis, cell growth and proliferation, and mTORC2, which is a regulator of the actin cytoskeleton, and promotes cell survival and cell cycle progression. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. Inhibitors of mTOR are used in organ transplants as immunosuppressants, and are being evaluated for their therapeutic potential in SARS-CoV-2 infections. Mutations in this gene are associated with Smith-Kingsmore syndrome and somatic focal cortical dysplasia type II. The ANGPTL7 gene is located in an intron of this gene. [provided by RefSeq, Aug 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.